Transcriptional up-regulation of interleukin 4 receptors by human immunodeficiency virus type 1 tat gene

AIDS Research and Human Retroviruses

Volumn 12, Issue 14, 1996, Pages 1349-1359

  Husain, S Rafat ^a   Leland, Pamela ^a   Aggarwal, Bharat B ^b   Puri, Raj K ^a  

^a CENTER FOR BIOLOGICS EVALUATION AND RESEARCH   (United States)

^b UNIVERSITY OF TEXAS MD ANDERSON CANCER CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

INTERLEUKIN 4 RECEPTOR;

ARTICLE; HUMAN IMMUNODEFICIENCY VIRUS 1; NONHUMAN; PRIORITY JOURNAL; PROTEIN CROSS LINKING; PROTEIN PROCESSING; PROTEIN STABILITY; RAJI CELL; REGULATOR GENE; TRANSCRIPTION REGULATION; VIRUS REPLICATION; VIRUS TRANSCRIPTION;

EID: 0029817040     PISSN: 08892229     EISSN: None     Source Type: Journal    
DOI: 10.1089/aid.1996.12.1349     Document Type: Article

References (64)

1. Fauci AS: The human immunodeficiency virus: Infectivity and mechanism of pathogenesis. Science 1988;239:617-622.
2. Vaishnav YN and Wong-Staal F: The biochemistry of AIDS. Annu Rev Biochem 1991;60:577-630.
3. Cullen BR: Regulation of HIV-1 gene expression. FASEB J 1991;5:2361-2368.
4. Arya SK, Cuo C, Joseph SF, and Wong-Staal F: Trans-activator gene of human T lymphotropic virus type III (HTLV-III). Trans-acting transcriptional regulation of human T-cell leukemia virus type III long terminal repeat. Science 1985;229:69-73.
5. Sodorski JG, Rosen CA, Wong-Staal F, Salahuddin SZ, Popovic M, Arya SK, Gallo RC, and Haseltine WA: Trans-acting transcriptional regulation of human T-cell leukemia virus type III long terminal repeat. Science 1985;227:171-173.
6. Marciniak RA, Garcia-Blanco MA, and Sharp PA: Identification and characterization of a HeLa nuclear protein that specifically binds to the trans-activation-response (TAR) element of human immunodeficiency virus. Proc Natl Acad Sci USA 1990;87: 3624-3628.
7. Selby MJ, and Peterlin BM: Trans-activation by HIV-1 Tat via a heterologous RNA binding protein. Cell 1990;62:769-776.
8. Weeks KM, Ampe C, Schultz SC, Steitz TA, and Crothers DM: Fragments of the HIV-1 Tat protein specifically bind TAR RNA. Science 1990;249:1281-1285.
9. Frankel AD, and Pabo CO: Cellular uptake of Tat protein from human immunodeficiency virus. Cell 1988;55:1189-1193.
10. Mann DA, and Frankel AD: Endocytosis and targeting of exogenous HIV-1 tat protein. EMBO 1991;10:1733-1739.
11. Ensoli B, Barillari G, Salahuddin SZ, Gallo RC, and Wong-Staal F: Tat protein of HIV-1 stimulates growth of cells derived from Kaposi's sarcoma lesion of AIDS patients: Nature (London) 1990;345:84-86.
12. Ensoli B, Buonaguro L, Barillari G, Fiorelli V, Gendelman R, Morgan RA, Wingfield P, and Gallo RC: Release, uptake and effects of extracellular human immunodeficiency virus type 1 tat protein on cell growth and viral transactivation. J Virol 1993;67:277-287.
13. Barillari G, Buonaguro L, Fiorelli V, Hoffman J, Michaels F, Gallo RC, and Ensoli B: Effects of cytokine from activated immune cells on vascular cell growth and HIV-1 gene expression. J Immunol 1992;149:3727-3734.
14. Sastry RJ, Reddy RHR, Pandita R, Totpal K, and Aggarwal BB: HIV-1 tat gene induces tumor necrosis factor-β (lymphotoxin) in a human B-lymphoblastoid cell line. J Biol Chem 1990;265:20091-20093.
15. Rautonen N, Rautonen N, Martin NL, Wara DW: HIV-1 Tat induces cytokine synthesis by uninfected mononuclear cells. AIDS 1994;8:1504-1506.
16. Pocsik E, Higuchi M, and Aggarwal BB: Down modulation of cell surface expression of p80 form of the tumor necrosis factor receptor by human immunodeficiency virus-1 tat gene. Lymphokine Cytokine Res 1992;61:317-325.
17. Howcroft TK, Strebel K, Mortin MA, and Singer DS: Repression of MHC class I gene promoter activity by two-exon Tat of HIV. Science 1993;260:1320-1322.
18. Buonaguro L, Barillari G, Chang HK, Bohan CA, Rao V, Morgan R, and Gallo RC: Effects of the human immunodeficiency virus type 1 Tat protein on the expression of inflammatory cytokines. J Virol 1992;6:7159-7167.
19. Pun RK, Leland P, and Aggarwal BB: Constitutive expression of human immunodeficiency virus type 1 tat gene inhibits interleukin 2 and interleukin 2 receptor expression in a human CD4+ T lymphoid (H9) cell line. AIDS Res Human Retroviruses 1995;11:31-40.
20. Purvis SF, Georges DL, Williams TM, and Lederman MM: Suppression of interleukin-2 and interleukin-2 receptor expression in Jurkat cells stably expressing the human immunodeficiency virus Tat protein. Cell Immunol 1992;144:32-42.
21. Koka P, Yunis J, Passarelli AL, Dubey PP, Faller DV, and Yunis EJ: Increased expression of CD4 molecules on jurkat cells mediated by human immunodeficiency virus Tat protein. J Virol 1988;62:4353-4357.
22. Flores SC, Marecki JC, Harper KP, Bose SK, Nelson SK, and McCord JM: Tat protein of human immunodeficiency virus type 1 represses expression of manganese superoxide dismutase in HeLa cells. Proc Natl Acad Sci USA 1993;90:7632-7636.
23. Taylor JP, Cupp C, Diaz A, Chowdhury M, Khalili K, Jimenez SA, and Amini S: Activation of expression of genes coding for extracellular matrix proteins in Tat-producing glioblastoma cells. Proc Natl Acad Sci 1992;89:9617-9621.
24. Paul WE: Interleukin 4: A prototypic immunoregulatory lymphokine. Blood 1991;77:1859-1870.
25. Puri RK, and Siegel JP: Interleukin-4 and cancer therapy. Cancer Invest 1993;11:479-486.
26. Puri RK: Structure and functions of interleukin 4 and its receptors. In Cytokines: Interleukins and Their Receptors. Kurzock R, and Talpaz M (Eds). Kluwer Academic Publishers, Norwell, MA, 1995, pp 143-185.
27. Gazinelli RT, Makino M, Chattopadhyay SK, Snapper CM, Sher A, Hughin AW, and Morse HC III: CD4+ subset regulation in viral infection: Preferential activation of Th2 cells during progression of retrovirus-induced immunodeficiency in mice. J Immunol 1992;148:182-186.
28. Clerici M, Hakim FT, Venzom DJ, Blatt S, Hendrix CW, Wynn TA, and Shearer GM: Changes in interleukin-2 and interleukin-4 production in asymptomatic, human immunodeficiency virus-seropositive individuals. J Clin Invest 1993;93:759-765.
29. Kanagawa O, Vaupel BA, Gayama S, Koehler G, and Kopf M: Resistance of mice deficient in IL-4 to retrovirus-induced immunodeficiency syndrome (MAIDS). Science 1993;262:240-242.
30. H0s. Science 1994;265:244-248.
31. H2 predominance in HIV-infected individuals. Science 1994;265:248-252.
32. Murata T, Noguchi PD, and Puri RK: Receptors for IL-4 do not associate with the common γ chain and IL-4 induces the phosphorylation of JAK2 tyrosin kinase in human colon carcinoma cells. J Biol Chem 1995;270:30829-30836.
33. Puri RK, and Aggarwal BB: Human immunodeficiency virus type 1 tat gene up-regulates interleukin 4 receptors on a human B-lymphoblastoid cell line. Cancer Res 1992;52:3783-3790.
34. Obiri NI, Hillman GG, Haas GP, Sudha S, and Puri RK: Expression of high affinity interleukin-4 receptors on human renal cell carcinoma cells and inhibition of tumor cell growth in vitro by interleukin 4. J Clin Invest 1993;91:83-89.
35. Kashanchi F, Duvall JF, and Brady JN: EIectroporation of viral transactivator protein into lymphocyte suspension cell. Nucleic Acids Res 1992;20:4673-4674.
36. Munson PJ, and Rodbard D: Ligand: A versatile computerized approach for characterization of ligand-binding systems. Anal Biochem 1980;107:220-239.
37. Laemmli U.K.: Cleavage of structural proteins during the assembly of the head of bacteriphage. Nature (London) 1970;227:680-685.
38. Sambrook J, Fritsch EF, and Maniatis, T: Molecular Cloning: A Laboratory Manual, 2nd ed. Cold Spring Harbor Laboratory, Cold Spring Harbor, NY, 1989.
39. Kronke M, Leonard WJ. Deeper JM, Arya SK, Wong-Staal F, Gallo RC, Waldmann TA, and Greene WC: Cyclosporin inhibits T-cell growth factor gene expression at the level of mRNA expression. Proc Natl Acad Sci USA 1994;81:5214-5218.
40. Groudine M, Peretz M, and Weintraub H: Transcriptional regulation of hemoglobin switching in chicken embryos. Mol Cell Biol 1981;1:281-288.
41. Keegan AD, Beckman MP, Park LS, and Paul WE: The IL-4 receptor: biochemical characterization of IL-4 binding molecules in a T cell line expressing large number of receptors. J Immunol 1991;146:2272-2279.
42. Galizzi JP, Zuber CE, Cabrillat H, Ait YS, Barret R, Howard M, and Banchereau J: Internalization of human interleukin-4 and transient down regulation of its receptor in the CD23 inducible Jijoye cells. J Biol Chem 1989;264:6984-6989.
43. Galizzi JP, Zuber CE, Cabrillat H, Ait YS, Barrett R, Howard M, and Banchereau J: Purification of 130 kDa T cell glycoprotein which binds human interleukin-4 with high affinity. J Biol Chem 1990;265:439-444.
44. Foxwell BMJ, Woerly G, and Ryffel B: Identification of interleukin 4 receptor-associated proteins and expression of both high and low affinity binding on human lymphoid cells. Eur J Immunol 1989;19:1637-1641.
45. Russell SM, Keegan AD, Harada N, Nakamura Y, Noguchi M, Leland P, Freidman MC, Miyajima A, Pun RK, Paul WE, and Leonard WJ: Interleukin-2 receptor gamma chain: A functional component of the interleukin-4 receptor. Science 1993;262: 1880-1883.
46. Obiri NI, Debinski W, Leonard WJ, and Pun RK: Receptor for interleukin 13: Interaction with interleukin 4 by a mechanism that does not involve the common γ chain shared by receptors for interleukin 2, 4, 7, 9, and 15. J Biol Chem 1994;270:8797-8804.
47. Puri RK, and Leland P: Tumor necrosis factor upregulales interleukin-4 receptors on murine sarcoma ceels. Biochem Biophys Res Commun 1993;197:1424-1430.
48. Mosley B, Beckmann P, March CJ, Idzerda RL, Gimpel SD, Vandenbos T, Friend D, Alpert A, Anderson D, Jackson J, Wignall JM, Smith G, Gallis B, Sims JE, Urdal D, Widmer MB, Cosman D, and Park LS: The murine interleukin-4 receptor: molecular cloning and characterization of secreted and membrane bound forms. Cell 1989;59:335-348.
49. Kondo M, Takeshita T, Ishii M, Nakamura S, Watanabe K-I, Arai K, Sugamura S: Sharing of interleukin-2 (IL-2) receptor γ chain between receptors for IL-2 and IL-4. Science 1993;262:1874-1877.
50. Hofman HM, Wright AD, Dohadwala MM, Wong-Staal F, and Walker SM: Exogenous Tat protein activates human endothelial cells. Blood 1993;82:2774-2780.
51. Darnell JE Jr, Kerr IM, and Stark GR: JAK-STAT pathways and transcriptional activation in response to IFNs and other extracellular signaling proteins. Science 1994;264:1415-1421.
52. Hou J, Schindler U, Henzel WJ, Ho TC, Brasseur M, and McKnight SL: An interleukin-4-induced transcription factor: IL-4 Stat. Science 1994;265:1701-1706.
53. Schindler C, Kashleva H, Pernis A, Pine R, and Rothman P: STF-IL-4: A novel IL-4-induced signal transducing factor. EMBO J 1994;13:1350-1356.
54. Clerici M, and Shearer GM: The Thl-Th2 hypothesis of HIV infection: New insight. Immunol Today 1994;15:575-581.
55. Park LS, Friend D, Sassenfeld HM, and Urdal DL: Characterization of the human B cell stimulatory factor 1 receptor. J Exp Med 1987;166:476-468.
56. Renz A, Domenico J, and Gelfand EW: IL-4 dependent up-regulation of IL-4 receptor expression in murine T and B cells. J Immunol 1991;146:3049-3055.
57. Zurowski A, and deVries JE: Interleukin 13, an interleukin 4-like cytokine that acts on monocytes and B cells, but not on T cells. Immunol Today 1994;15:19-26.
58. Weeks BS, Desai K, Loewenstein PM, Klotman ME, Klotman PE, Green M, and Kleinman HK: Identification of novel cell attachment domain in the HIV-1 tat protein and its 90-kDa cell surface binding protein. J Biol Chem 1993;268:5279-5284.
59. Hays EF, Vittenbogaart CF, Brewer JC, Volger LW, and Zack JA: In vitro studies of HIV-1 expression in thymocytes from infants and children. AIDS 1992;6:265-272.
60. Novak RM, Holzer TJ, Kennedy MM, Heynen CA, and Dawson G: The effect of Interleukin-4 (BSF-1) on infection of peripheral blood monocytes-derived macrophages with HIV-1. AIDS Res Human Retroviruses 1990;6:973-976.
61. Kazzazi F, Mathijs JM, Chang J, Malafiej P, Lopez A, Dowton D, Sorrell TC, Vadas MA, and Cunningham AL: Recombinant interleukin 4 stimulates human immunodeficiency virus production by infected monocytes and macrophages. J Gen Virol 1992;73: 941-949.
62. Kombluth RS, Oh PS, Munis JR, Cleveland PH, and Richman DD: Interferons and bacterial lipopolysaccharide protect macrophages from productiove infection by human immunodeficiency virus in vitro. J Exp Med 1989;169:1137-1151.
63. Schuitemaker H, Kootstra NA, Koppelman MHGM, Bruisten MHG, Tersmette M, and Miedema F: Proliferation-dependent HIV-1 infection of monocytes occurs during differentiation into macrophages. J Clin Invest 1992;89:1154-1160.
64. Viscidi RP, Kumudin M, Lederman HM, and Frankel AD: Inhibition of antigen-induced lymphocyte proliferation by Tat protein from HIV-1. Science 1989;246:1606-1608.